Literature DB >> 7811049

Nucleotide sequence of a plasmid-mediated cephalosporinase gene (blaLAT-1) found in Klebsiella pneumoniae.

L S Tzouvelekis1, E Tzelepi, A F Mentis.   

Abstract

The nucleotide sequence of the gene encoding a novel cephalosporinase (LAT-1), carried by a non-self-transferable plasmid from Klebsiella pneumoniae, has been determined. It was found that the sequence shares a high degree of homology with the Citrobacter freundii OS60 ampC structural gene.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7811049      PMCID: PMC284714          DOI: 10.1128/AAC.38.9.2207

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  13 in total

1.  Characterization of the plasmid mediated beta-lactamase BIL-1.

Authors:  D J Payne; N Woodford; S G Amyes
Journal:  J Antimicrob Chemother       Date:  1992-08       Impact factor: 5.790

2.  Binding of the Citrobacter freundii AmpR regulator to a single DNA site provides both autoregulation and activation of the inducible ampC beta-lactamase gene.

Authors:  S Lindquist; F Lindberg; S Normark
Journal:  J Bacteriol       Date:  1989-07       Impact factor: 3.490

Review 3.  Extended-spectrum beta-lactamases.

Authors:  A Philippon; R Labia; G Jacoby
Journal:  Antimicrob Agents Chemother       Date:  1989-08       Impact factor: 5.191

4.  Function of the conserved triad residues in the class C beta-lactamase from Citrobacter freundii GN346.

Authors:  K Tsukamoto; N Nishida; M Tsuruoka; T Sawai
Journal:  FEBS Lett       Date:  1990-10-01       Impact factor: 4.124

5.  Cloning and sequence analysis of blaBIL-1, a plasmid-mediated class C beta-lactamase gene in Escherichia coli BS.

Authors:  A P Fosberry; D J Payne; E J Lawlor; J E Hodgson
Journal:  Antimicrob Agents Chemother       Date:  1994-05       Impact factor: 5.191

6.  Identification of the active site of Citrobacter freundii beta-lactamase using dansyl-penicillin.

Authors:  A Yamaguchi; H Adachi; T Sawai
Journal:  FEBS Lett       Date:  1987-06-22       Impact factor: 4.124

7.  DNA sequencing with chain-terminating inhibitors.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

8.  Sequence of the Citrobacter freundii OS60 chromosomal ampC beta-lactamase gene.

Authors:  F Lindberg; S Normark
Journal:  Eur J Biochem       Date:  1986-05-02

9.  Extended broad spectrum beta-lactamase in Klebsiella pneumoniae including resistance to cephamycins.

Authors:  A Bauernfeind; Y Chong; S Schweighart
Journal:  Infection       Date:  1989 Sep-Oct       Impact factor: 3.553

10.  Novel plasmid-mediated beta-lactamase (MIR-1) conferring resistance to oxyimino- and alpha-methoxy beta-lactams in clinical isolates of Klebsiella pneumoniae.

Authors:  G A Papanicolaou; A A Medeiros; G A Jacoby
Journal:  Antimicrob Agents Chemother       Date:  1990-11       Impact factor: 5.191

View more
  18 in total

Review 1.  Plasmid-determined AmpC-type beta-lactamases.

Authors:  Alain Philippon; Guillaume Arlet; George A Jacoby
Journal:  Antimicrob Agents Chemother       Date:  2002-01       Impact factor: 5.191

2.  Detection of plasmid-mediated AmpC beta-lactamase genes in clinical isolates by using multiplex PCR.

Authors:  F Javier Pérez-Pérez; Nancy D Hanson
Journal:  J Clin Microbiol       Date:  2002-06       Impact factor: 5.948

3.  Carbapenem resistance in Escherichia coli associated with plasmid-determined CMY-4 beta-lactamase production and loss of an outer membrane protein.

Authors:  P D Stapleton; K P Shannon; G L French
Journal:  Antimicrob Agents Chemother       Date:  1999-05       Impact factor: 5.191

4.  Escherichia coli with a self-transferable, multiresistant plasmid coding for metallo-beta-lactamase VIM-1.

Authors:  Vivi Miriagou; Eva Tzelepi; Dimitra Gianneli; Leonidas S Tzouvelekis
Journal:  Antimicrob Agents Chemother       Date:  2003-01       Impact factor: 5.191

5.  First detection of the Ambler class C 1 AmpC beta-lactamase in Citrobacter freundii by a new, simple double-disk synergy test.

Authors:  Etienne Ruppé; Philippe Bidet; Charlotte Verdet; Guillaume Arlet; Edouard Bingen
Journal:  J Clin Microbiol       Date:  2006-09-13       Impact factor: 5.948

6.  In vitro activity of cefpirome against selected clinical enterobacterial isolates with beta-lactamase-mediated resistance.

Authors:  L S Tzouvelekis; E Tzelepi; A F Mentis; N J Legakis
Journal:  Infection       Date:  1995 Nov-Dec       Impact factor: 3.553

7.  Study of an outbreak of cefoxitin-resistant Klebsiella pneumoniae in a general hospital.

Authors:  M Gazouli; M E Kaufmann; E Tzelepi; H Dimopoulou; O Paniara; L S Tzouvelekis
Journal:  J Clin Microbiol       Date:  1997-02       Impact factor: 5.948

8.  Comparative evaluation of the inhibitory activities of the novel penicillanic acid sulfone Ro 48-1220 against beta-lactamases that belong to groups 1, 2b, and 2be.

Authors:  L S Tzouvelekis; M Gazouli; E E Prinarakis; E Tzelepi; N J Legakis
Journal:  Antimicrob Agents Chemother       Date:  1997-02       Impact factor: 5.191

9.  Identification of CMY-2-type cephalosporinases in clinical isolates of Enterobacteriaceae by MALDI-TOF MS.

Authors:  C C Papagiannitsis; S D Kotsakis; Z Tuma; M Gniadkowski; V Miriagou; J Hrabak
Journal:  Antimicrob Agents Chemother       Date:  2014-02-24       Impact factor: 5.191

10.  Dissemination of CTX-M-3 and CMY-2 beta-lactamases among clinical isolates of Escherichia coli in southern Taiwan.

Authors:  J J Yan; W C Ko; S H Tsai; H M Wu; Y T Jin; J J Wu
Journal:  J Clin Microbiol       Date:  2000-12       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.